Abionyx Pharma annual debt-to-assets ratio
2019
2020
2021
2022
2023
2024
2025
Abionyx Pharma Debt-to-Assets Ratio Growth & History (ABNX)
Abionyx Pharma's debt-to-assets ratio was 0.29 for fiscal 2025.
View full Abionyx Pharma company overviewAbionyx Pharma annual debt-to-assets ratio history
| Fiscal year | Period ended | Debt-to-assets ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 0.29 | 0.09 | +42.50% |
| 2024 | 2024-12-31 | 0.20 | −0.02 | −10.91% |
| 2023 | 2023-12-31 | 0.23 | −0.03 | −9.89% |
| 2022 | 2022-12-31 | 0.25 | 0.06 | +28.62% |
| 2021 | 2021-12-31 | 0.20 | 0.19 | +8352.78% |
| 2020 | 2020-12-31 | 0.00 | −0.01 | −71.19% |
| 2019 | 2019-12-31 | 0.01 | — | — |
Abionyx Pharma quarterly debt-to-assets ratio
Q4.24
Q4.25
| Fiscal quarter | Period ended | Debt-to-assets ratio | Change | YoY change |
|---|---|---|---|---|
| Q4 2025 | 2025-12-31 | 0.29 | 0.09 | +42.50% |
| Q4 2024 | 2024-12-31 | 0.20 | — | — |
Abionyx Pharma debt-to-assets ratio trends
Over the last five fiscal years, Abionyx Pharma's debt-to-assets ratio increased from 0.00 to 0.29, a change of 0.29. The latest reported quarter, Q4 2025, shows 0.29.
About the metric
What the debt-to-assets ratio means
The debt-to-assets ratio shows the portion of a company’s reported assets financed with interest-bearing debt. It is a leverage measure and should not be confused with total liabilities divided by assets.
Calculation and source
How debt-to-assets is calculated
TickerStat calculates debt-to-assets as total interest-bearing debt divided by total assets at the same reporting-period end. Periods with missing debt or non-positive assets are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Abionyx Pharma source filings ↗